nodes	percent_of_prediction	percent_of_DWPC	metapath
Droperidol—HTR2A—choroid plexus—brain cancer	0.0904	0.124	CbGeAlD
Droperidol—HTR2A—trigeminal nerve—brain cancer	0.0457	0.0627	CbGeAlD
Droperidol—HTR2A—cerebellar cortex—brain cancer	0.0455	0.0624	CbGeAlD
Droperidol—HTR2A—vein—brain cancer	0.0413	0.0567	CbGeAlD
Droperidol—DRD2—telencephalic ventricle—brain cancer	0.0401	0.0551	CbGeAlD
Droperidol—HTR2A—cranial nerve—brain cancer	0.0326	0.0447	CbGeAlD
Droperidol—HTR2A—pons—brain cancer	0.0322	0.0441	CbGeAlD
Droperidol—HTR2A—telencephalic ventricle—brain cancer	0.0265	0.0363	CbGeAlD
Droperidol—DRD2—ganglion—brain cancer	0.025	0.0343	CbGeAlD
Droperidol—HTR2A—pineal body—brain cancer	0.023	0.0315	CbGeAlD
Droperidol—ADRA1A—hindbrain—brain cancer	0.0193	0.0265	CbGeAlD
Droperidol—DRD2—hindbrain—brain cancer	0.019	0.026	CbGeAlD
Droperidol—HTR2A—ganglion—brain cancer	0.0165	0.0226	CbGeAlD
Droperidol—Altered state of consciousness—Temozolomide—brain cancer	0.0143	0.0534	CcSEcCtD
Droperidol—HTR2A—endothelium—brain cancer	0.0142	0.0195	CbGeAlD
Droperidol—HTR2A—blood vessel—brain cancer	0.0131	0.018	CbGeAlD
Droperidol—HTR2A—hindbrain—brain cancer	0.0125	0.0171	CbGeAlD
Droperidol—Amenorrhoea—Procarbazine—brain cancer	0.0124	0.0464	CcSEcCtD
Droperidol—ADRA1A—brainstem—brain cancer	0.0111	0.0152	CbGeAlD
Droperidol—DRD2—brainstem—brain cancer	0.0109	0.0149	CbGeAlD
Droperidol—ADRA1A—telencephalon—brain cancer	0.00984	0.0135	CbGeAlD
Droperidol—Gynaecomastia—Procarbazine—brain cancer	0.00978	0.0365	CcSEcCtD
Droperidol—DRD2—telencephalon—brain cancer	0.00964	0.0132	CbGeAlD
Droperidol—Amenorrhoea—Hydroxyurea—brain cancer	0.00963	0.0359	CcSEcCtD
Droperidol—KCNH2—telencephalon—brain cancer	0.0095	0.013	CbGeAlD
Droperidol—Extrapyramidal disorder—Temozolomide—brain cancer	0.00878	0.0327	CcSEcCtD
Droperidol—DRD2—pituitary gland—brain cancer	0.00785	0.0108	CbGeAlD
Droperidol—KCNH2—pituitary gland—brain cancer	0.00773	0.0106	CbGeAlD
Droperidol—Amenorrhoea—Temozolomide—brain cancer	0.00752	0.028	CcSEcCtD
Droperidol—KCNH2—medulla oblongata—brain cancer	0.00746	0.0102	CbGeAlD
Droperidol—HTR2A—brainstem—brain cancer	0.00717	0.00983	CbGeAlD
Droperidol—Laryngospasm—Etoposide—brain cancer	0.00709	0.0264	CcSEcCtD
Droperidol—DRD2—midbrain—brain cancer	0.00692	0.00949	CbGeAlD
Droperidol—KCNH2—midbrain—brain cancer	0.00682	0.00936	CbGeAlD
Droperidol—KCNH2—spinal cord—brain cancer	0.00666	0.00913	CbGeAlD
Droperidol—HTR2A—telencephalon—brain cancer	0.00636	0.00872	CbGeAlD
Droperidol—ADRA1A—endocrine gland—brain cancer	0.0062	0.00851	CbGeAlD
Droperidol—ADRA1A—head—brain cancer	0.00612	0.0084	CbGeAlD
Droperidol—Gynaecomastia—Carmustine—brain cancer	0.00612	0.0228	CcSEcCtD
Droperidol—Drowsiness—Procarbazine—brain cancer	0.00612	0.0228	CcSEcCtD
Droperidol—DRD2—endocrine gland—brain cancer	0.00608	0.00834	CbGeAlD
Droperidol—DRD2—head—brain cancer	0.006	0.00823	CbGeAlD
Droperidol—KCNH2—endocrine gland—brain cancer	0.00599	0.00822	CbGeAlD
Droperidol—KCNH2—head—brain cancer	0.00592	0.00811	CbGeAlD
Droperidol—ADRA1A—central nervous system—brain cancer	0.00559	0.00767	CbGeAlD
Droperidol—Body temperature increased—Carboplatin—brain cancer	0.00555	0.0207	CcSEcCtD
Droperidol—DRD2—central nervous system—brain cancer	0.00548	0.00752	CbGeAlD
Droperidol—ADRA1A—cerebellum—brain cancer	0.00546	0.00749	CbGeAlD
Droperidol—Hallucination—Procarbazine—brain cancer	0.00546	0.0204	CcSEcCtD
Droperidol—KCNH2—central nervous system—brain cancer	0.0054	0.0074	CbGeAlD
Droperidol—DRD2—cerebellum—brain cancer	0.00536	0.00735	CbGeAlD
Droperidol—HTR2A—gonad—brain cancer	0.00531	0.00728	CbGeAlD
Droperidol—KCNH2—cerebellum—brain cancer	0.00528	0.00724	CbGeAlD
Droperidol—HTR2A—pituitary gland—brain cancer	0.00518	0.0071	CbGeAlD
Droperidol—HTR2A—medulla oblongata—brain cancer	0.005	0.00685	CbGeAlD
Droperidol—Chills—Procarbazine—brain cancer	0.00493	0.0184	CcSEcCtD
Droperidol—Body temperature increased—Lomustine—brain cancer	0.00486	0.0181	CcSEcCtD
Droperidol—Drowsiness—Hydroxyurea—brain cancer	0.00473	0.0176	CcSEcCtD
Droperidol—HTR2A—midbrain—brain cancer	0.00457	0.00626	CbGeAlD
Droperidol—HTR2A—spinal cord—brain cancer	0.00446	0.00611	CbGeAlD
Droperidol—ADRA1A—brain—brain cancer	0.00444	0.00609	CbGeAlD
Droperidol—DRD2—brain—brain cancer	0.00435	0.00597	CbGeAlD
Droperidol—Syncope—Procarbazine—brain cancer	0.00429	0.016	CcSEcCtD
Droperidol—KCNH2—brain—brain cancer	0.00429	0.00588	CbGeAlD
Droperidol—Hallucination—Hydroxyurea—brain cancer	0.00423	0.0158	CcSEcCtD
Droperidol—Loss of consciousness—Procarbazine—brain cancer	0.0042	0.0157	CcSEcCtD
Droperidol—Hypertension—Procarbazine—brain cancer	0.00413	0.0154	CcSEcCtD
Droperidol—Anxiety—Procarbazine—brain cancer	0.00406	0.0151	CcSEcCtD
Droperidol—HTR2A—endocrine gland—brain cancer	0.00401	0.0055	CbGeAlD
Droperidol—HTR2A—head—brain cancer	0.00396	0.00543	CbGeAlD
Droperidol—Hyperglycaemia—Carmustine—brain cancer	0.00387	0.0144	CcSEcCtD
Droperidol—Shock—Procarbazine—brain cancer	0.00384	0.0143	CcSEcCtD
Droperidol—Depression—Carmustine—brain cancer	0.00382	0.0142	CcSEcCtD
Droperidol—Chills—Hydroxyurea—brain cancer	0.00381	0.0142	CcSEcCtD
Droperidol—Tachycardia—Procarbazine—brain cancer	0.00381	0.0142	CcSEcCtD
Droperidol—Hyperglycaemia—Temozolomide—brain cancer	0.00374	0.0139	CcSEcCtD
Droperidol—Depression—Temozolomide—brain cancer	0.00369	0.0137	CcSEcCtD
Droperidol—Cardiac arrest—Etoposide—brain cancer	0.00365	0.0136	CcSEcCtD
Droperidol—Hypotension—Procarbazine—brain cancer	0.00365	0.0136	CcSEcCtD
Droperidol—HTR2A—central nervous system—brain cancer	0.00361	0.00496	CbGeAlD
Droperidol—HTR2A—cerebellum—brain cancer	0.00353	0.00484	CbGeAlD
Droperidol—Somnolence—Procarbazine—brain cancer	0.00347	0.0129	CcSEcCtD
Droperidol—Hallucination—Carmustine—brain cancer	0.00342	0.0127	CcSEcCtD
Droperidol—Hallucination—Temozolomide—brain cancer	0.0033	0.0123	CcSEcCtD
Droperidol—Bronchospasm—Etoposide—brain cancer	0.00327	0.0122	CcSEcCtD
Droperidol—Body temperature increased—Procarbazine—brain cancer	0.00308	0.0115	CcSEcCtD
Droperidol—Chills—Temozolomide—brain cancer	0.00298	0.0111	CcSEcCtD
Droperidol—Hypersensitivity—Procarbazine—brain cancer	0.00287	0.0107	CcSEcCtD
Droperidol—HTR2A—brain—brain cancer	0.00287	0.00394	CbGeAlD
Droperidol—Somnolence—Hydroxyurea—brain cancer	0.00268	0.01	CcSEcCtD
Droperidol—Angioedema—Temozolomide—brain cancer	0.00264	0.00984	CcSEcCtD
Droperidol—Hypertension—Carmustine—brain cancer	0.00258	0.00962	CcSEcCtD
Droperidol—Dizziness—Procarbazine—brain cancer	0.00258	0.00962	CcSEcCtD
Droperidol—Palpitations—Temozolomide—brain cancer	0.00255	0.00952	CcSEcCtD
Droperidol—Anxiety—Carmustine—brain cancer	0.00254	0.00946	CcSEcCtD
Droperidol—Haloperidol—CYP2C9—brain cancer	0.00253	1	CrCbGaD
Droperidol—Hypertension—Temozolomide—brain cancer	0.0025	0.0093	CcSEcCtD
Droperidol—Rash—Procarbazine—brain cancer	0.00246	0.00917	CcSEcCtD
Droperidol—Dermatitis—Procarbazine—brain cancer	0.00246	0.00916	CcSEcCtD
Droperidol—Anxiety—Temozolomide—brain cancer	0.00245	0.00914	CcSEcCtD
Droperidol—Body temperature increased—Hydroxyurea—brain cancer	0.00239	0.0089	CcSEcCtD
Droperidol—Chills—Etoposide—brain cancer	0.00238	0.00889	CcSEcCtD
Droperidol—Tachycardia—Carmustine—brain cancer	0.00238	0.00888	CcSEcCtD
Droperidol—Anaphylactic shock—Temozolomide—brain cancer	0.00236	0.00879	CcSEcCtD
Droperidol—Hypotension—Carmustine—brain cancer	0.00228	0.0085	CcSEcCtD
Droperidol—Hypersensitivity—Hydroxyurea—brain cancer	0.00222	0.00829	CcSEcCtD
Droperidol—Somnolence—Carmustine—brain cancer	0.00217	0.00809	CcSEcCtD
Droperidol—Somnolence—Temozolomide—brain cancer	0.0021	0.00782	CcSEcCtD
Droperidol—Loss of consciousness—Etoposide—brain cancer	0.00203	0.00758	CcSEcCtD
Droperidol—Hypertension—Etoposide—brain cancer	0.002	0.00744	CcSEcCtD
Droperidol—Dizziness—Hydroxyurea—brain cancer	0.002	0.00744	CcSEcCtD
Droperidol—Body temperature increased—Carmustine—brain cancer	0.00193	0.00719	CcSEcCtD
Droperidol—Rash—Hydroxyurea—brain cancer	0.0019	0.0071	CcSEcCtD
Droperidol—Dermatitis—Hydroxyurea—brain cancer	0.0019	0.00709	CcSEcCtD
Droperidol—Anaphylactic shock—Etoposide—brain cancer	0.00189	0.00704	CcSEcCtD
Droperidol—Body temperature increased—Temozolomide—brain cancer	0.00186	0.00695	CcSEcCtD
Droperidol—Tachycardia—Etoposide—brain cancer	0.00184	0.00687	CcSEcCtD
Droperidol—Hypersensitivity—Carmustine—brain cancer	0.0018	0.0067	CcSEcCtD
Droperidol—Hypotension—Etoposide—brain cancer	0.00176	0.00657	CcSEcCtD
Droperidol—Hypersensitivity—Temozolomide—brain cancer	0.00174	0.00648	CcSEcCtD
Droperidol—Somnolence—Etoposide—brain cancer	0.00168	0.00625	CcSEcCtD
Droperidol—Dizziness—Carmustine—brain cancer	0.00161	0.00602	CcSEcCtD
Droperidol—Dizziness—Temozolomide—brain cancer	0.00156	0.00581	CcSEcCtD
Droperidol—Rash—Carmustine—brain cancer	0.00154	0.00574	CcSEcCtD
Droperidol—Dermatitis—Carmustine—brain cancer	0.00154	0.00573	CcSEcCtD
Droperidol—Body temperature increased—Etoposide—brain cancer	0.00149	0.00556	CcSEcCtD
Droperidol—Rash—Temozolomide—brain cancer	0.00149	0.00554	CcSEcCtD
Droperidol—Dermatitis—Temozolomide—brain cancer	0.00149	0.00554	CcSEcCtD
Droperidol—Hypersensitivity—Etoposide—brain cancer	0.00139	0.00518	CcSEcCtD
Droperidol—Dizziness—Etoposide—brain cancer	0.00125	0.00465	CcSEcCtD
Droperidol—Rash—Etoposide—brain cancer	0.00119	0.00444	CcSEcCtD
Droperidol—Dermatitis—Etoposide—brain cancer	0.00119	0.00443	CcSEcCtD
